Outcome as a measure of quality of care in oncology

Experience at Sultan Qaboos university hospital, Oman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives: Measurement of outcomes is increasingly employed as an indicator of the quality of clinical care. The most commonly measured outcome in many clinical studies, especially in oncology, still remains the overall survival rate. Sultan Qaboos University Hospital (SQUH), Oman, is striving for excellence through quality management. In seeking continual improvement, quality measurement exercises have been initiated throughout the Hospital. We present the overall survival rate of four of the ten most common cancers diagnosed in Oman. Methods: The cancers included non-Hodgkin’s lymphoma (NHL), Hodgkin’s lymphoma (HL), breast cancer, and stomach cancer. The studies were all retrospective and had been conducted previously. For present purposes, only the overall survival was compared with studies both from the region, and with bench-mark studies. Results: For NHL, with a median follow-up of 8 months, the 2-year overall survival rate was 64%; 90% for low risk, 55% for intermediate risk, and 15% for high risk groups. For HL, the 5-year overall survival rate was 64%; 76% for low risk and 42% for high risk. For breast cancer, the 5-year survival rate was 67%; percentages were 88%, 75% and 59% for Groups I, II, and III respectively. For gastric cancer, the 5-year survival rate was 16.5 %; 24% for the non-metastatic group. Conclusion: The outcome of patients with early stages and fewer adverse prognostic factors is comparable to what has been reported in the international literature; however, the outcome is inferior for patients presenting with advanced stage disease and several adverse prognostic factors.

Original languageEnglish
Pages (from-to)27-36
Number of pages10
JournalSultan Qaboos University Medical Journal
Volume8
Issue number1
Publication statusPublished - Mar 1 2008

Fingerprint

Oman
Quality of Health Care
Survival Rate
Stomach Neoplasms
Hodgkin Disease
Non-Hodgkin's Lymphoma
Breast Neoplasms
Sultan
Neoplasms
Exercise
Survival

Keywords

  • Cancer, Breast
  • Cancer, Gastric
  • Lymphoma, Hodgkin’s
  • Lymphoma, Non-Hodgkin
  • Oman
  • Oncology
  • Outcome assessment
  • Quality indicators

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{376536963dac43298c6285515bd4eb47,
title = "Outcome as a measure of quality of care in oncology: Experience at Sultan Qaboos university hospital, Oman",
abstract = "Objectives: Measurement of outcomes is increasingly employed as an indicator of the quality of clinical care. The most commonly measured outcome in many clinical studies, especially in oncology, still remains the overall survival rate. Sultan Qaboos University Hospital (SQUH), Oman, is striving for excellence through quality management. In seeking continual improvement, quality measurement exercises have been initiated throughout the Hospital. We present the overall survival rate of four of the ten most common cancers diagnosed in Oman. Methods: The cancers included non-Hodgkin’s lymphoma (NHL), Hodgkin’s lymphoma (HL), breast cancer, and stomach cancer. The studies were all retrospective and had been conducted previously. For present purposes, only the overall survival was compared with studies both from the region, and with bench-mark studies. Results: For NHL, with a median follow-up of 8 months, the 2-year overall survival rate was 64{\%}; 90{\%} for low risk, 55{\%} for intermediate risk, and 15{\%} for high risk groups. For HL, the 5-year overall survival rate was 64{\%}; 76{\%} for low risk and 42{\%} for high risk. For breast cancer, the 5-year survival rate was 67{\%}; percentages were 88{\%}, 75{\%} and 59{\%} for Groups I, II, and III respectively. For gastric cancer, the 5-year survival rate was 16.5 {\%}; 24{\%} for the non-metastatic group. Conclusion: The outcome of patients with early stages and fewer adverse prognostic factors is comparable to what has been reported in the international literature; however, the outcome is inferior for patients presenting with advanced stage disease and several adverse prognostic factors.",
keywords = "Cancer, Breast, Cancer, Gastric, Lymphoma, Hodgkin’s, Lymphoma, Non-Hodgkin, Oman, Oncology, Outcome assessment, Quality indicators",
author = "Burney, {Ikram A.} and {Al Moundhri}, {Mansour S.} and Rizvi, {Azhar J.} and Ganguly, {Shyam S.} and {Al Abri}, Rashid and Ashra, {Rafi A.}",
year = "2008",
month = "3",
day = "1",
language = "English",
volume = "8",
pages = "27--36",
journal = "Sultan Qaboos University Medical Journal",
issn = "2075-051X",
publisher = "Sultan Qaboos University",
number = "1",

}

TY - JOUR

T1 - Outcome as a measure of quality of care in oncology

T2 - Experience at Sultan Qaboos university hospital, Oman

AU - Burney, Ikram A.

AU - Al Moundhri, Mansour S.

AU - Rizvi, Azhar J.

AU - Ganguly, Shyam S.

AU - Al Abri, Rashid

AU - Ashra, Rafi A.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Objectives: Measurement of outcomes is increasingly employed as an indicator of the quality of clinical care. The most commonly measured outcome in many clinical studies, especially in oncology, still remains the overall survival rate. Sultan Qaboos University Hospital (SQUH), Oman, is striving for excellence through quality management. In seeking continual improvement, quality measurement exercises have been initiated throughout the Hospital. We present the overall survival rate of four of the ten most common cancers diagnosed in Oman. Methods: The cancers included non-Hodgkin’s lymphoma (NHL), Hodgkin’s lymphoma (HL), breast cancer, and stomach cancer. The studies were all retrospective and had been conducted previously. For present purposes, only the overall survival was compared with studies both from the region, and with bench-mark studies. Results: For NHL, with a median follow-up of 8 months, the 2-year overall survival rate was 64%; 90% for low risk, 55% for intermediate risk, and 15% for high risk groups. For HL, the 5-year overall survival rate was 64%; 76% for low risk and 42% for high risk. For breast cancer, the 5-year survival rate was 67%; percentages were 88%, 75% and 59% for Groups I, II, and III respectively. For gastric cancer, the 5-year survival rate was 16.5 %; 24% for the non-metastatic group. Conclusion: The outcome of patients with early stages and fewer adverse prognostic factors is comparable to what has been reported in the international literature; however, the outcome is inferior for patients presenting with advanced stage disease and several adverse prognostic factors.

AB - Objectives: Measurement of outcomes is increasingly employed as an indicator of the quality of clinical care. The most commonly measured outcome in many clinical studies, especially in oncology, still remains the overall survival rate. Sultan Qaboos University Hospital (SQUH), Oman, is striving for excellence through quality management. In seeking continual improvement, quality measurement exercises have been initiated throughout the Hospital. We present the overall survival rate of four of the ten most common cancers diagnosed in Oman. Methods: The cancers included non-Hodgkin’s lymphoma (NHL), Hodgkin’s lymphoma (HL), breast cancer, and stomach cancer. The studies were all retrospective and had been conducted previously. For present purposes, only the overall survival was compared with studies both from the region, and with bench-mark studies. Results: For NHL, with a median follow-up of 8 months, the 2-year overall survival rate was 64%; 90% for low risk, 55% for intermediate risk, and 15% for high risk groups. For HL, the 5-year overall survival rate was 64%; 76% for low risk and 42% for high risk. For breast cancer, the 5-year survival rate was 67%; percentages were 88%, 75% and 59% for Groups I, II, and III respectively. For gastric cancer, the 5-year survival rate was 16.5 %; 24% for the non-metastatic group. Conclusion: The outcome of patients with early stages and fewer adverse prognostic factors is comparable to what has been reported in the international literature; however, the outcome is inferior for patients presenting with advanced stage disease and several adverse prognostic factors.

KW - Cancer, Breast

KW - Cancer, Gastric

KW - Lymphoma, Hodgkin’s

KW - Lymphoma, Non-Hodgkin

KW - Oman

KW - Oncology

KW - Outcome assessment

KW - Quality indicators

UR - http://www.scopus.com/inward/record.url?scp=84922593363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922593363&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 27

EP - 36

JO - Sultan Qaboos University Medical Journal

JF - Sultan Qaboos University Medical Journal

SN - 2075-051X

IS - 1

ER -